Valeant Pharmaceuticals International (TSX: VRX), the Canada-based healthcare major, has seen its shares fall sharply in the last six months. Indeed, the entire healthcare sector globally has come under pressure due to concerns over a range of issue, including drug pricing. However, the long-term fundamentals of the sector remain promising. Pharmaceutical and biotechnology companies have been spending billions of dollars to bring new treatment options to the market. These efforts will create significant value for shareholders in healthcare companies in the long-term. Investors can gain exposure to the healthcare sector through these ETFs.
iShares S&P Global Healthcare Index Fund Canadian Dollar Hedged (ETF) (TSX: XHC)
The ETF seeks to provide long-term capital growth by replicating the performance of the S&P Global 1200 Healthcare Canadian Dollar Hedged Index. Over the last five years, the ETF has returned 87.1%.
BMO Equal Weight U.S. Healthcare Hedged Index (ETF) (TSX: ZUH)
The ETF has been designed to replicate he performance of the Dow Jones U.S. Large-Cap Health Care Equal Weight Total Stock Market Index. While year-to-date the ETF is down nearly 8%, over the last five years it has returned 125%.
